Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Argon-Helium Cryoablation Combined With PD-1 Inhibitors in Non-Small Cell Lung Cancer: A Randomized Controlled Trial

NCT07053215 is registered in ClinicalTrials.gov with The First Hospital of Hebei Medical University as lead sponsor.

NCT NCT07053215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07053215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Argon-Helium Cryoablation Combined With PD-1 Inhibitors in Non-Small Cell Lung Cancer: A Randomized Controlled Trial
Lead sponsor
The First Hospital of Hebei Medical University
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2020
Completion date
December 1, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (nsclc)